Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk

Journal of Steroid Biochemistry and Molecular Biology

Volumn 132, Issue 1-2, 2012, Pages 73-79

  Pruthi, Sandhya ^a   Yang, Li ^b   Sandhu, Nicole P ^a   Ingle, James N ^a   Beseler, Cheryl L ^c   Suman, Vera J ^a   Cavalieri, Ercole L ^b   Rogan, Eleanor G ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Biomarker; Breast cancer; Breast cancer prevention; Depurinating estrogen DNA adducts

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; DNA ADDUCT; ESTROGEN BLOOD LEVEL; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN;

ADULT; AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; DNA ADDUCTS; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; RISK;

EID: 84864437349     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.02.002     Document Type: Article

References (19)

1. American Cancer Society, Cancer Facts & Figures, 2011. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ cancer-facts-figures-2011 (accessed 15.11.11).
2. E. Cavalieri, D. Chakravarti, J. Guttenplan, E. Hart, J. Ingle, R. Jankowiak, P. Muti, E. Rogan, J. Russo, R. Santen, and T. Sutter Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention Biochim. Biophys. Acta 1766 2006 63 78 (Pubitemid 44175632)
3. E.L. Cavalieri, and E.G. Rogan Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers Future Oncol. 6 2010 75 91
4. D. Chakravarti, P.C. Mailander, K.M. Li, S. Higginbotham, H.L. Zhang, M.L. Gross, J.L. Meza, E.L. Cavalieri, and E.G. Rogan Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene Oncogene 20 2001 7945 7953 (Pubitemid 34001555)
5. P.C. Mailander, J.L. Meza, S. Higginbotham, and D. Chakravarti Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats J. Steroid Biochem. Mol. Biol. 101 2006 204 215 (Pubitemid 44573805)
6. Z. Zhao, W. Kosinska, M. Khmelnitsky, E.L. Cavalieri, E.G. Rogan, D. Chakravarti, P.G. Sacks, and J.B. Guttenplan Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol Chem. Res. Toxicol. 19 2006 475 479
7. F. Lu, M. Zahid, M. Saeed, E.L. Cavalieri, and E.G. Rogan Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition J. Steroid Biochem. Mol. Biol. 105 2007 150 158 (Pubitemid 47211948)
8. M. Zahid, M. Saeed, F. Lu, N. Gaikwad, E. Rogan, and E. Cavalieri Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation Free Radic. Biol. Med. 43 2007 1534 1540 (Pubitemid 47615397)
9. N.W. Gaikwad, E.G. Rogan, and E.L. Cavalieri Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones Free Radic. Biol. Med. 43 2007 1289 1298 (Pubitemid 47429941)
10. N.W. Gaikwad, L. Yang, E.G. Rogan, and E.L. Cavalieri Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones Free Radic. Biol. Med. 46 2009 253 262
11. E.L. Cavalieri, S. Kumar, R. Todorovic, S. Higginbotham, A.F. Badawi, and E.G. Rogan Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors Chem. Res. Toxicol. 14 2001 1041 1050 (Pubitemid 32800160)
12. E.G. Rogan, A.F. Badawi, P.D. Devanesan, J.L. Meza, J.A. Edney, W.W. West, S.M. Higginbotham, and E.L. Cavalieri Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer Carcinogenesis 24 2003 697 702 (Pubitemid 36592404)
13. S. Singh, D. Chakravarti, J.A. Edney, R.R. Hollins, P.J. Johnson, W.W. West, S.M. Higginbotham, E.L. Cavalieri, and E.G. Rogan Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma Oncol. Rep. 14 2005 1091 1096
14. W. Wen, Z. Ren, X.O. Shu, Q. Cai, C. Ye, Y.T. Gao, and W. Zheng Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk Cancer Epidemiol. Biomarkers Prev. 16 2007 917 920 (Pubitemid 46910092)
15. N.W. Gaikwad, L. Yang, P. Muti, J.L. Meza, S. Pruthi, J.N. Ingle, E.G. Rogan, and E.L. Cavalieri The molecular etiology of breast cancer: evidence from biomarkers of risk Int. J. Cancer 122 2008 1949 1957 (Pubitemid 351441183)
16. N. Gaikwad, L. Yang, S. Pruthi, J. Ingle, N. Sandhu, E. Rogan, and E. Cavalieri Urine biomarkers of risk in the molecular etiology of breast cancer Breast Cancer: Basic Clin. Res. 3 2009 1 8
17. M.H. Gail, L.A. Brinton, D.P. Byar, D.K. Corle, S.B. Green, C. Schairer, and J.J. Mulvihill Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J. Natl. Cancer Inst. 81 1989 1879 1886 (Pubitemid 20026073)
18. D.M. Euhus, A.M. Leitch, J.F. Huth, and G.N. Peters Limitations of the Gail model in the specialized breast cancer risk assessment clinic Breast J. 8 2002 23 27 (Pubitemid 34118480)
19. V.S. Pankratz, L.C. Hartmann, A.C. Degnim, R.A. Vierkant, K. Ghosh, C.M. Vachon, M.H. Frost, S.D. Maloney, C. Reynolds, and J.C. Boughey Assessment of the accuracy of the Gail model in women with atypical hyperplasia J. Clin. Oncol. 26 2008 5374 5379